Prasanna Kumar

1.1k total citations
42 papers, 582 citations indexed

About

Prasanna Kumar is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Prasanna Kumar has authored 42 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in Prasanna Kumar's work include Acute Myeloid Leukemia Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer-related Molecular Pathways (5 papers). Prasanna Kumar is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer-related Molecular Pathways (5 papers). Prasanna Kumar collaborates with scholars based in United States, India and Japan. Prasanna Kumar's co-authors include Johanna C. Bendell, Andres Forero, Dmitry I. Gabrilovich, Sridevi Mony, Qin Liu, Thomas Condamine, Robert L. Witt, Fang Wang, Ayumi Hashimoto and Neil Hockstein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Prasanna Kumar

39 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prasanna Kumar United States 12 244 186 152 109 94 42 582
M. Bianchi Italy 12 191 0.8× 330 1.8× 40 0.3× 110 1.0× 115 1.2× 43 704
Fumihiro Kimura Japan 12 84 0.3× 271 1.5× 92 0.6× 175 1.6× 82 0.9× 39 628
Magdalena Chechlińska Poland 15 370 1.5× 246 1.3× 186 1.2× 80 0.7× 113 1.2× 38 790
Masafumi Inokuchi Japan 16 241 1.0× 178 1.0× 35 0.2× 114 1.0× 73 0.8× 61 663
Piero De Carli Italy 15 135 0.6× 221 1.2× 37 0.2× 399 3.7× 209 2.2× 34 821
Silvia Ursino Italy 12 188 0.8× 168 0.9× 67 0.4× 40 0.4× 151 1.6× 23 528
Ming Y. Tung United States 8 200 0.8× 245 1.3× 73 0.5× 51 0.5× 209 2.2× 9 578
Ramin Rabbani United States 6 74 0.3× 95 0.5× 62 0.4× 91 0.8× 38 0.4× 11 583
G Delides Greece 18 254 1.0× 279 1.5× 39 0.3× 123 1.1× 298 3.2× 51 855

Countries citing papers authored by Prasanna Kumar

Since Specialization
Citations

This map shows the geographic impact of Prasanna Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasanna Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasanna Kumar more than expected).

Fields of papers citing papers by Prasanna Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasanna Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasanna Kumar. The network helps show where Prasanna Kumar may publish in the future.

Co-authorship network of co-authors of Prasanna Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Prasanna Kumar. A scholar is included among the top collaborators of Prasanna Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasanna Kumar. Prasanna Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Li, Muharrem Müftüoğlu, Koichi Iwanaga, et al.. (2025). Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3 -ITD Mutant/ TP53 Wild-type Acute Myeloid Leukemias. Clinical Cancer Research. 31(14). 3033–3047.
2.
George, Suzanne, Michael C. Heinrich, Neeta Somaiah, et al.. (2023). A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor. Clinical Cancer Research. 29(18). 3659–3667. 9 indexed citations
3.
Kumar, Prasanna, et al.. (2022). Influence of Serum Levels of Vitamin D on Insulin Resistance in Patients with Type II Diabetes Mellitus. Journal of the Association of Physicians of India. 70(7). 28–32. 1 indexed citations
4.
Nishida, Yuki, Kiyomi Morita, Tomoyuki Tanaka, et al.. (2020). Clonal Expansion of Mutant p53 Clones By MDM2 Inhibition in Acute Myeloid Leukemias. Blood. 136(Supplement 1). 27–28. 1 indexed citations
5.
Kumar, Prasanna, et al.. (2020). Microalbuminuria can predict the development of acute kidney injury in intensive care unit admission. International Journal of Advances in Medicine. 7(9). 1372–1372. 1 indexed citations
6.
Khoury, Thaer, et al.. (2017). Neuroendocrine Carcinoma of the Breast With Endobronchial Metastases and Syndrome of Inappropriate Antidiuretic Hormone Secretion. Clinical Breast Cancer. 17(5). e229–e232. 1 indexed citations
7.
Vidyasagar, Rishma, et al.. (2017). Carotid artery intimal media thickness and ankle brachial index as predictors for atherosclerosis in pre-diabetic patients. International Journal of Medical Science and Public Health. 6(10). 1–1.
8.
Forero, Andres, Johanna C. Bendell, Prasanna Kumar, et al.. (2017). First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors. Investigational New Drugs. 35(3). 298–306. 30 indexed citations
9.
Dominguez, George A., Thomas Condamine, Sridevi Mony, et al.. (2016). Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody. Clinical Cancer Research. 23(12). 2942–2950. 152 indexed citations
10.
Rai, Sushma, et al.. (2016). Feasibility and acceptability of ambulatory glucose profile in children with Type 1 diabetes mellitus: A pilot study. Indian Journal of Endocrinology and Metabolism. 20(6). 790–794. 17 indexed citations
11.
DiNardo, Courtney D., Joseph Rosenthal, Michael Andreeff, et al.. (2016). Phase 1 Dose Escalation Study of MDM2 Inhibitor DS-3032b in Patients with Hematological Malignancies - Preliminary Results. Blood. 128(22). 593–593. 29 indexed citations
12.
Kumar, Prasanna, et al.. (2015). Multicentric Trial of Diabecon (D-400)- A Herbomineral Preparation on Lipid Profile in Diabetes Mellitus. 1 indexed citations
13.
Bauer, Todd M., David S. Hong, Neeta Somaiah, et al.. (2015). Abstract B27: A phase I dose escalation study of the MDM2 inhibitor DS-3032b in patients with advanced solid tumors and lymphomas. Molecular Cancer Therapeutics. 14(12_Supplement_2). B27–B27. 4 indexed citations
14.
Kumar, Prasanna, et al.. (2014). Occupational inhalation of aniline fumes induced methemoglobinemea and hemolytic anemia precipitated days later. Indian Journal of Occupational and Environmental Medicine. 18(2). 95–95. 3 indexed citations
15.
Pitale, Shailesh, Mathew Thomas, Gaurav Rathi, et al.. (2014). A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis. Indian Journal of Endocrinology and Metabolism. 19(1). 148–148. 11 indexed citations
16.
Kumar, Prasanna, et al.. (2012). Evaluation of serum vitamin B12 levels in type 1 diabetics attending a tertiary care hospital: A preliminary cross - sectional study. Indian Journal of Endocrinology and Metabolism. 16(7). 79–79. 8 indexed citations
17.
Gottlieb, Ronald H., Prasanna Kumar, Peter Loud, et al.. (2009). Semiquantitative Visual Approach to Scoring Lung Cancer Treatment Response Using Computed Tomography. Journal of Computer Assisted Tomography. 33(5). 743–747. 3 indexed citations
18.
Litwin, Alan, Prasanna Kumar, Jeffrey Lombardo, et al.. (2009). Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II–III Colorectal Cancer. Oncology. 76(5). 363–368. 42 indexed citations
19.
20.
Kumar, Prasanna, et al.. (2002). Proteomics of renal disorders: Urinary proteome analysis by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. NOT FOUND REPOSITORY (Indian Institute of Science Bangalore). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Bianchi Breakdown of academic impact, for papers by Fumihiro Kimura Breakdown of academic impact, for papers by Magdalena Chechlińska Breakdown of academic impact, for papers by Masafumi Inokuchi Breakdown of academic impact, for papers by Piero De Carli Breakdown of academic impact, for papers by Silvia Ursino Breakdown of academic impact, for papers by Ming Y. Tung Breakdown of academic impact, for papers by Ramin Rabbani Breakdown of academic impact, for papers by G Delides
Rankless by CCL
2026